Radford D M, Cromack D T, Troop B R, Keller S M, Lopez M J
Department of Surgery, Washington University, St. Louis, Missouri.
Am J Surg. 1992 Nov;164(5):427-31; discussion 431-2. doi: 10.1016/s0002-9610(05)81174-2.
With the increasing use of mammography, more needle-localized breast biopsies (NLBB) are being done. The purpose of this study was to analyze the pathology of impalpable breast lesions and the impact of NLBB on treatment strategies. From 1985 to 1990, 1,605 NLBB were performed, of which 321 (20%) were malignant. Twenty-five percent of malignant biopsies demonstrated in situ disease only. The average size of all lesions detected was 16 mm, and, for invasive cancer, 12 mm. Eighteen percent of invasive cancers had metastasized to the axillary lymph nodes. Surgical management consisted of mastectomy in 74% of patients and breast conservation treatment (BCT) in 26%. No significant difference in surgical management for women 50 years of age or younger compared with those older than 50 years of age was noted. Although the use of BCT for eligible women is recommended by the National Institutes of Health, it is not widely practiced, possibly reflecting less physician acceptance of BCT. These observations suggest that the detection of smaller, impalpable breast cancers has had no impact on treatment strategies.
随着乳腺X线摄影的使用日益增加,进行的针吸定位乳腺活检(NLBB)也越来越多。本研究的目的是分析不可触及乳腺病变的病理学特征以及NLBB对治疗策略的影响。1985年至1990年期间,共进行了1605例NLBB,其中321例(20%)为恶性。25%的恶性活检仅显示原位疾病。所有检测到的病变平均大小为16毫米,浸润性癌的平均大小为12毫米。18%的浸润性癌已转移至腋窝淋巴结。手术治疗包括74%的患者行乳房切除术和26%的患者行保乳治疗(BCT)。未发现50岁及以下女性与50岁以上女性在手术治疗方面有显著差异。尽管美国国立卫生研究院建议对符合条件的女性使用BCT,但该方法并未广泛应用,这可能反映出医生对BCT的接受度较低。这些观察结果表明,较小的、不可触及的乳腺癌的检测对治疗策略没有影响。